114 related articles for article (PubMed ID: 7053826)
21. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
22. The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.
Flavell DJ; Wright DH
Br J Cancer; 1989 Feb; 59(2):165-73. PubMed ID: 2495015
[TBL] [Abstract][Full Text] [Related]
23. Impairment of lymphocyte transformation by plasma from patients with advanced Hodgkin's disease.
Sugden PJ; Lilleyman JS
Cancer; 1980 Mar; 45(5):899-905. PubMed ID: 7260841
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
Bobrove AM; Fuks Z; Strober S; Kaplan HS
Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
[TBL] [Abstract][Full Text] [Related]
25. In vitro lymphocyte dysfunction in Hodgkin's disease.
Graze PR; Perlin E; Royston I
J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
[TBL] [Abstract][Full Text] [Related]
26. In vitro lymphocyte response to the phytomitogens in untreated and treated patients with Hodgkin's disease.
Romagnani S; Amadori A; Biti G; Bellesi G; Ricci M
Int Arch Allergy Appl Immunol; 1976; 51(3):378-89. PubMed ID: 1279027
[TBL] [Abstract][Full Text] [Related]
27. Quantitative and functional abnormalities of total T lymphocytes in relatives of patients with Hodgkin's disease.
del Giacco GS; Cengiarotti L; Mantovani G; Murgia M; Broccia G; Corda G; di Tucci A
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):793-801. PubMed ID: 3876218
[TBL] [Abstract][Full Text] [Related]
28. Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. I. Reciprocal effect on T and B rosette formation.
Shoham J; Cohen M; Chandali Y; Avni A
Immunology; 1980 Oct; 41(2):353-9. PubMed ID: 6969219
[TBL] [Abstract][Full Text] [Related]
29. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
[TBL] [Abstract][Full Text] [Related]
30. Study of some immunological parameters in untreated patients with Hodgkin's disease.
Romagnani S; Amadori A; Maggi E; Biagiotti R; Ricci M
Int Arch Allergy Appl Immunol; 1977; 55(1-6):429-38. PubMed ID: 145416
[No Abstract] [Full Text] [Related]
31. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
32. Altered proportion of T mu-and T gamma-cell subpopulations in patients with Hodgkin's disease.
Romagnani S; Maggi E; Biagiotti R; Giudizi MG; Amadori A; Ricci M
Scand J Immunol; 1978; 7(6):511-4. PubMed ID: 308257
[TBL] [Abstract][Full Text] [Related]
33. [The T-lymphocytes in allergic asthmatic children: influence in-vitro of thymostimulin of E rosette forming activity].
Armenio L; Diaferia P; Patano M; Santostasi T; Brunetti L; Spadavecchia F; Mingozzi A; Altavilla P
Pediatria (Napoli); 1981 Sep; 89(3):297-303. PubMed ID: 6981095
[No Abstract] [Full Text] [Related]
34. Radiosensitivity of Hodgkin's disease lymphocytes.
Baral E; Blomgren H; Rotstein S
J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
[TBL] [Abstract][Full Text] [Related]
35. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
36. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
37. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
38. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.
Liberati AM; Ballatori E; Fizzotti M; Schippa M; Cini L; Cinieri S; Proietti MG; Di Marzio R; Senatore M; Grignani F
Cancer Immunol Immunother; 1988; 26(1):87-93. PubMed ID: 3125973
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
40. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
Panteghini M; Piccioli E; Migliorati T; Ruggeri G
Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
